Amicus Therapeutics, Inc.
NASDAQ:FOLD
Overview | Financials
| Company Name | Amicus Therapeutics, Inc. |
| Symbol | FOLD |
| Currency | USD |
| Price | 7.98 |
| Market Cap | 2,459,747,220 |
| Dividend Yield | 0% |
| 52-week-range | 5.51 - 12.65 |
| Industry | Biotechnology |
| Sector | Healthcare |
| CEO | Mr. Bradley L. Campbell M.B.A. |
| Website | https://amicusrx.com |
An error occurred while fetching data.
About Amicus Therapeutics, Inc.
Amicus Therapeutics, Inc., a biotechnology company, focuses on discovering, developing, and delivering medicines for rare diseases. Its commercial product and product candidates include Galafold, an oral precision medicine for the treatment of adults with a confirmed diagnosis of Fabry disease and an amenable galactosidase alpha gene variant based on in
Related Stocks
Financials
Numbers are in millions USD
Numbers are in millions USD









